ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
-0,04%
Bitcoin
63.277,95
0,12%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Achieve Life Sciences Inc (ACHV)

  7. Achieve Life Sciences Inc (ACHV) News

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACHV
DatumZeitQuelleÜberschriftSymbolFirma
26/08/202422h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
26/08/202422h30GlobeNewswire Inc.Achieve Life Sciences Announces Changes in Executive Leadership and Board of DirectorsNASDAQ:ACHVAchieve Life Sciences Inc
20/08/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
20/08/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
20/08/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
13/08/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
13/08/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
13/08/202422h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
31/07/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine DependenceNASDAQ:ACHVAchieve Life Sciences Inc
29/07/202414h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
29/07/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley BankNASDAQ:ACHVAchieve Life Sciences Inc
25/07/202414h00GlobeNewswire Inc.Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024NASDAQ:ACHVAchieve Life Sciences Inc
09/07/202414h00GlobeNewswire Inc.Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024NASDAQ:ACHVAchieve Life Sciences Inc
09/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACHVAchieve Life Sciences Inc
01/07/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® IndexesNASDAQ:ACHVAchieve Life Sciences Inc
06/06/202423h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
29/05/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-CigarettesNASDAQ:ACHVAchieve Life Sciences Inc
20/05/202423h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACHVAchieve Life Sciences Inc
17/05/202420h56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACHVAchieve Life Sciences Inc
17/05/202414h00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
09/05/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
09/05/202422h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
07/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACHVAchieve Life Sciences Inc
06/05/202417h16GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineNASDAQ:ACHVAchieve Life Sciences Inc
25/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024NASDAQ:ACHVAchieve Life Sciences Inc
11/04/202414h00GlobeNewswire Inc.Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceNASDAQ:ACHVAchieve Life Sciences Inc
28/03/202421h01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
20/03/202413h00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
14/03/202413h00GlobeNewswire Inc.Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024NASDAQ:ACHVAchieve Life Sciences Inc
06/03/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ACHV

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
DBI
SDXP
SDAX
CCOM
US500
US 500
TG
BAS
BASF
NYSE
MCD
McDonalds
CCOM
US100
US Tech 100
TG
MBG
MercedesBenz
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
TG
CBK
Commerzbank
TG
LHA
Deutsche Lufthansa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten